VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,420,826 | -56.7% | 127,121 | -38.4% | 0.03% | -61.4% |
Q1 2022 | $7,909,000 | +25.3% | 206,231 | +11.1% | 0.09% | -1.1% |
Q2 2021 | $6,310,000 | +86.0% | 185,694 | +77.9% | 0.09% | +71.2% |
Q1 2021 | $3,392,000 | -47.4% | 104,382 | -41.7% | 0.05% | -51.4% |
Q4 2020 | $6,452,000 | +18.1% | 179,114 | +28.4% | 0.11% | +3.9% |
Q3 2020 | $5,461,000 | -6.5% | 139,443 | -12.4% | 0.10% | -5.5% |
Q2 2020 | $5,842,000 | +6.1% | 159,266 | -33.3% | 0.11% | -22.1% |
Q1 2020 | $5,505,000 | -17.8% | 238,950 | +4.4% | 0.14% | 0.0% |
Q4 2019 | $6,701,000 | +129.1% | 228,849 | +109.0% | 0.14% | +112.1% |
Q3 2019 | $2,925,000 | -40.9% | 109,521 | -53.3% | 0.07% | -50.4% |
Q4 2018 | $4,947,000 | +8.2% | 234,573 | +17.8% | 0.13% | -13.6% |
Q3 2017 | $4,572,000 | +65.2% | 199,117 | +58.9% | 0.15% | +42.6% |
Q2 2017 | $2,767,000 | +645.8% | 125,331 | +792.1% | 0.11% | +414.3% |
Q3 2016 | $371,000 | -81.1% | 14,049 | -80.1% | 0.02% | -83.5% |
Q2 2016 | $1,960,000 | – | 70,733 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |